Yantai Dongcheng Biochemicals Co., Ltd.

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100001DP5
CNY
13.16
0.59 (4.69%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
2,722.60
2,852.41
3,257.21
3,566.48
3,890.97
3,399.35
2,972.12
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
2,722.60
2,852.41
3,257.21
3,566.48
3,890.97
3,399.35
2,972.12
Raw Material Cost
1,423.99
1,592.20
1,857.76
2,089.56
2,352.61
1,789.65
1,247.08
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
138.94
98.23
59.32
61.99
59.03
51.48
60.63
Selling and Distribution Expenses
721.28
705.60
713.95
767.52
783.45
877.54
981.62
Other Expenses
6.48
16.15
12.38
8.54
6.46
4.42
1.80
Total Expenditure (Excl Depreciation)
2,349.05
2,557.52
2,754.80
3,004.45
3,259.66
2,762.92
2,307.31
Operating Profit (PBDIT) excl Other Income
373.6
294.9
502.40000000000003
562
631.3000000000001
636.4
664.8000000000001
Other Income
21.22
145.78
78.73
79.86
32.20
35.38
41.48
Operating Profit (PBDIT)
593.38
601.84
607.27
759.43
764.65
766.62
794.00
Interest
138.94
98.23
59.32
61.99
59.03
51.48
60.63
Exceptional Items
0.90
-84.73
-19.47
-79.70
-210.09
1.05
-240.12
Gross Profit (PBDT)
1,298.61
1,260.21
1,399.45
1,476.92
1,538.36
1,609.70
1,725.04
Depreciation
219.87
174.48
153.44
130.44
119.46
106.14
99.06
Profit Before Tax
235.48
244.39
375.03
487.29
376.07
610.05
394.19
Tax
57.00
77.68
83.07
92.75
95.25
93.90
102.12
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
195.63
183.83
209.74
307.29
151.56
417.77
154.71
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
195.63
183.83
209.74
307.29
151.56
417.77
154.71
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-41.19
-42.40
44.48
45.54
109.29
99.71
138.93
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
154.44
141.43
254.22
352.83
260.85
517.47
293.64
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
4,350.05
4,480.44
4,775.40
4,748.66
4,397.42
4,468.32
4,292.71
Earnings per share (EPS)
0.24
0.22
0.25
0.38
0.19
0.52
0.19
Diluted Earnings per share
0.24
0.22
0.25
0.38
0.19
0.52
0.19
Operating Profit Margin (Excl OI)
12.94%
9.87%
11.52%
15.4%
15.75%
18.39%
21.99%
Gross Profit Margin
16.72%
14.68%
16.22%
17.32%
12.74%
21.07%
16.6%
PAT Margin
7.19%
6.44%
6.44%
8.62%
3.9%
12.29%
5.21%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2025 is -4.55% vs -12.43% in Dec 2024

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2025 is 9.19% vs -44.37% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2025 is 25.45% vs -13.70% in Dec 2024

stock-summary

Interest

YoY Growth in year ended Dec 2025 is 41.45% vs 65.60% in Dec 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2025 has improved from Dec 2024

Compare Annual Results Of Yantai Dongcheng Biochemicals Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
2,722.60
0
2,722.60
Other Operating Income
0.00
0.00
0.00
Total Operating income
2,722.60
0
2,722.60
Raw Material Cost
1,423.99
0
1,423.99
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
138.94
0
138.94
Selling and Distribution Expenses
721.28
0
721.28
Other Expenses
6.48
0.00
6.48
Total Expenditure (Excl Depreciation)
2,349.05
0
2,349.05
Operating Profit (PBDIT) excl Other Income
373.55
0.00
373.55
Other Income
21.22
0
21.22
Operating Profit (PBDIT)
593.38
0
593.38
Interest
138.94
0
138.94
Exceptional Items
0.90
0
0.90
Gross Profit (PBDT)
1,298.61
0
1,298.61
Depreciation
219.87
0
219.87
Profit Before Tax
235.48
0
235.48
Tax
57.00
0
57.00
Provisions and contingencies
0
0
0.00
Profit After Tax
195.63
0
195.63
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
195.63
0
195.63
Share in Profit of Associates
0
0
0.00
Minority Interest
-41.19
0
-41.19
Other related items
0.00
0.00
0.00
Consolidated Net Profit
154.44
0
154.44
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
4,350.05
0
4,350.05
Earnings per share (EPS)
0.24
0
0.24
Diluted Earnings per share
0.24
0
0.24
Operating Profit Margin (Excl OI)
12.94%
0%
0.00
12.94%
Gross Profit Margin
16.72%
0%
0.00
16.72%
PAT Margin
7.19%
0%
0.00
7.19%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 272.26 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is -4.55% vs -12.43% in Dec 2024

Annual - Consolidate Net Profit
Consolidate Net Profit 15.44 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 9.19% vs -44.37% in Dec 2024

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 57.22 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 25.45% vs -13.70% in Dec 2024

Annual - Interest
Interest 13.89 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 41.45% vs 65.60% in Dec 2024

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 12.94%
in Dec 2025

Figures in %
stock-summary

YoY Growth in year ended Dec 2025 has improved from Dec 2024